Analysis reveals adverse effects of complex cancer therapies called antibody drug conjugates
Over the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for use in patients. Investigators recently performed a comprehensive analysis ...
Nov 21, 2022
0
89
